The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Parexel International's, chairman and CEO, Mr Josef von Rickenbach, has been named the 2013 chairman of the ...
Singapore: Increasingly complex and inconsistent clinical trial regulations are causing delays, raising costs and leadin...
Singapore: WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device R&D services company with ope...
Singapore: Pharmaceutical Product Development (PPD) has appointed Dr Andrew Cunningham as vice president of central labo...
Singapore: Australian-based CRO, CPR Pharma Services, is launching a service aimed at US-based companies who want access...
Singapore: The toxicology facility of WuXi PharmaTech at Suzhou, China, has received a certificate of Good Laboratory Pr...
Big news in 2013 will be the growth of biosimilars in the biologics segment. By the end of the year, biosimilars will ac...
Singapore: Japan is considering new legislation to regulate clinical studies in the country, according to a report publi...
The bioservices sector witnessed a growth of 15.5 percent in 2011-12 in spite of facing many issues from the regulatory ...
Singapore: After four consecutive successful annual surveys on the developments in the clinical research industry, BioSp...
Singapore: In a move that will reduce time and cost of bringing new drugs to market, America's drug regulator, Food and ...
For many Asian pharmaceutical companies, pharmacovigilance is a critical component of any drug development program. As p...
Singapore: Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical d...
Dr Paul Hutchison, a healthcare professional and a parliamentarian from Hunua, New Zealand, has emerged as one-of-the-mo...
My father was an army officer and we saw frequent relocation, as a result of which we learned very early in life to adap...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Patrys has received approval to commence its planned phase I/IIa multiple myeloma trial with lead anti-canc...
